StreetInsider.com News Articles

Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado

Thu, 20 Mar 2025 07:00:00 -0400

VANCOUVER, BC, March 20, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, is proud to announce that its Psychedelic-Assisted Therapy Training Program has been officially approved by the state of Colorado, marking a significant milestone in the company's mission to expand safe and effective psychedelic-assisted therapy. This approval comes as part of Colorado's Natural Medicine Health Act (Proposition 122),

Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado

Thu, 20 Mar 2025 07:00:00 -0400

VANCOUVER, BC, March 20, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, is proud to announce that its Psychedelic-Assisted Therapy Training Program has been officially approved by the state of Colorado, marking a significant milestone in the company's mission to expand safe and effective psychedelic-assisted therapy. This approval comes as part of Colorado's Natural Medicine Health Act (Proposition 122),

Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado

Thu, 20 Mar 2025 07:00:00 -0400

VANCOUVER, BC, March 20, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, is proud to announce that its Psychedelic-Assisted Therapy Training Program has been officially approved by the state of Colorado, marking a significant milestone in the company's mission to expand safe and effective psychedelic-assisted therapy. This approval comes as part of Colorado's Natural Medicine Health Act (Proposition 122),

Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado

Thu, 20 Mar 2025 07:00:00 -0400

VANCOUVER, BC, March 20, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, is proud to announce that its Psychedelic-Assisted Therapy Training Program has been officially approved by the state of Colorado, marking a significant milestone in the company's mission to expand safe and effective psychedelic-assisted therapy. This approval comes as part of Colorado's Natural Medicine Health Act (Proposition 122),

Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado

Thu, 20 Mar 2025 07:00:00 -0400

VANCOUVER, BC, March 20, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, is proud to announce that its Psychedelic-Assisted Therapy Training Program has been officially approved by the state of Colorado, marking a significant milestone in the company's mission to expand safe and effective psychedelic-assisted therapy. This approval comes as part of Colorado's Natural Medicine Health Act (Proposition 122),

Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado

Thu, 20 Mar 2025 07:00:00 -0400

VANCOUVER, BC, March 20, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, is proud to announce that its Psychedelic-Assisted Therapy Training Program has been officially approved by the state of Colorado, marking a significant milestone in the company's mission to expand safe and effective psychedelic-assisted therapy. This approval comes as part of Colorado's Natural Medicine Health Act (Proposition 122),

Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado

Thu, 20 Mar 2025 07:00:00 -0400

VANCOUVER, BC, March 20, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, is proud to announce that its Psychedelic-Assisted Therapy Training Program has been officially approved by the state of Colorado, marking a significant milestone in the company's mission to expand safe and effective psychedelic-assisted therapy. This approval comes as part of Colorado's Natural Medicine Health Act (Proposition 122),

Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado

Thu, 20 Mar 2025 07:00:00 -0400

VANCOUVER, BC, March 20, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, is proud to announce that its Psychedelic-Assisted Therapy Training Program has been officially approved by the state of Colorado, marking a significant milestone in the company's mission to expand safe and effective psychedelic-assisted therapy. This approval comes as part of Colorado's Natural Medicine Health Act (Proposition 122),

Numinus Wellness Inc. Announces CFO Transition

Tue, 18 Feb 2025 18:35:00 -0400

VANCOUVER, BC, Feb. 18, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced a change in its Chief Financial Officer position. Effective February 18, 2025, Kelvin Yang will assume the role of Interim Chief Financial Officer, replacing Melony Valleau, who will be concluding her interim tenure at the end of February.

The Company thanks Ms. Valleau for her contributions and leadership during her tenure

Numinus Wellness Inc. Announces CFO Transition

Tue, 18 Feb 2025 18:35:00 -0400

VANCOUVER, BC, Feb. 18, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced a change in its Chief Financial Officer position. Effective February 18, 2025, Kelvin Yang will assume the role of Interim Chief Financial Officer, replacing Melony Valleau, who will be concluding her interim tenure at the end of February.

The Company thanks Ms. Valleau for her contributions and leadership during her tenure

Numinus Wellness Inc. Announces CFO Transition

Tue, 18 Feb 2025 18:35:00 -0400

VANCOUVER, BC, Feb. 18, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced a change in its Chief Financial Officer position. Effective February 18, 2025, Kelvin Yang will assume the role of Interim Chief Financial Officer, replacing Melony Valleau, who will be concluding her interim tenure at the end of February.

The Company thanks Ms. Valleau for her contributions and leadership during her tenure

Numinus Wellness Inc. Announces CFO Transition

Tue, 18 Feb 2025 18:35:00 -0400

VANCOUVER, BC, Feb. 18, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced a change in its Chief Financial Officer position. Effective February 18, 2025, Kelvin Yang will assume the role of Interim Chief Financial Officer, replacing Melony Valleau, who will be concluding her interim tenure at the end of February.

The Company thanks Ms. Valleau for her contributions and leadership during her tenure

Numinus Wellness Inc. Announces CFO Transition

Tue, 18 Feb 2025 18:35:00 -0400

VANCOUVER, BC, Feb. 18, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced a change in its Chief Financial Officer position. Effective February 18, 2025, Kelvin Yang will assume the role of Interim Chief Financial Officer, replacing Melony Valleau, who will be concluding her interim tenure at the end of February.

The Company thanks Ms. Valleau for her contributions and leadership during her tenure

Numinus Wellness Inc. Announces CFO Transition

Tue, 18 Feb 2025 18:35:00 -0400

VANCOUVER, BC, Feb. 18, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced a change in its Chief Financial Officer position. Effective February 18, 2025, Kelvin Yang will assume the role of Interim Chief Financial Officer, replacing Melony Valleau, who will be concluding her interim tenure at the end of February.

The Company thanks Ms. Valleau for her contributions and leadership during her tenure

Numinus Wellness Inc. Announces CFO Transition

Tue, 18 Feb 2025 18:35:00 -0400

VANCOUVER, BC, Feb. 18, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced a change in its Chief Financial Officer position. Effective February 18, 2025, Kelvin Yang will assume the role of Interim Chief Financial Officer, replacing Melony Valleau, who will be concluding her interim tenure at the end of February.

The Company thanks Ms. Valleau for her contributions and leadership during her tenure

Numinus Wellness Inc. Announces CFO Transition

Tue, 18 Feb 2025 18:35:00 -0400

VANCOUVER, BC, Feb. 18, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced a change in its Chief Financial Officer position. Effective February 18, 2025, Kelvin Yang will assume the role of Interim Chief Financial Officer, replacing Melony Valleau, who will be concluding her interim tenure at the end of February.

The Company thanks Ms. Valleau for her contributions and leadership during her tenure

Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries

Fri, 14 Feb 2025 17:00:00 -0400

VANCOUVER, BC, Feb. 14, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced that its Board of Directors has approved the wind-down of certain non-operating subsidiaries as part of the Company's efforts to simplify its corporate structure and concentrate resources on its core business areas. This initiative is intended to enhance operational efficiency and financial sustainability.

The subsidiaries affected and their respective wind-down methods

Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries

Fri, 14 Feb 2025 17:00:00 -0400

VANCOUVER, BC, Feb. 14, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced that its Board of Directors has approved the wind-down of certain non-operating subsidiaries as part of the Company's efforts to simplify its corporate structure and concentrate resources on its core business areas. This initiative is intended to enhance operational efficiency and financial sustainability.

The subsidiaries affected and their respective wind-down methods

Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries

Fri, 14 Feb 2025 17:00:00 -0400

VANCOUVER, BC, Feb. 14, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced that its Board of Directors has approved the wind-down of certain non-operating subsidiaries as part of the Company's efforts to simplify its corporate structure and concentrate resources on its core business areas. This initiative is intended to enhance operational efficiency and financial sustainability.

The subsidiaries affected and their respective wind-down methods

Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries

Fri, 14 Feb 2025 17:00:00 -0400

VANCOUVER, BC, Feb. 14, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced that its Board of Directors has approved the wind-down of certain non-operating subsidiaries as part of the Company's efforts to simplify its corporate structure and concentrate resources on its core business areas. This initiative is intended to enhance operational efficiency and financial sustainability.

The subsidiaries affected and their respective wind-down methods

Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries

Fri, 14 Feb 2025 17:00:00 -0400

VANCOUVER, BC, Feb. 14, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced that its Board of Directors has approved the wind-down of certain non-operating subsidiaries as part of the Company's efforts to simplify its corporate structure and concentrate resources on its core business areas. This initiative is intended to enhance operational efficiency and financial sustainability.

The subsidiaries affected and their respective wind-down methods

Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries

Fri, 14 Feb 2025 17:00:00 -0400

VANCOUVER, BC, Feb. 14, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced that its Board of Directors has approved the wind-down of certain non-operating subsidiaries as part of the Company's efforts to simplify its corporate structure and concentrate resources on its core business areas. This initiative is intended to enhance operational efficiency and financial sustainability.

The subsidiaries affected and their respective wind-down methods

Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries

Fri, 14 Feb 2025 17:00:00 -0400

VANCOUVER, BC, Feb. 14, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced that its Board of Directors has approved the wind-down of certain non-operating subsidiaries as part of the Company's efforts to simplify its corporate structure and concentrate resources on its core business areas. This initiative is intended to enhance operational efficiency and financial sustainability.

The subsidiaries affected and their respective wind-down methods

Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries

Fri, 14 Feb 2025 17:00:00 -0400

VANCOUVER, BC, Feb. 14, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced that its Board of Directors has approved the wind-down of certain non-operating subsidiaries as part of the Company's efforts to simplify its corporate structure and concentrate resources on its core business areas. This initiative is intended to enhance operational efficiency and financial sustainability.

The subsidiaries affected and their respective wind-down methods

Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries

Fri, 14 Feb 2025 17:00:00 -0400

VANCOUVER, BC, Feb. 14, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced that its Board of Directors has approved the wind-down of certain non-operating subsidiaries as part of the Company's efforts to simplify its corporate structure and concentrate resources on its core business areas. This initiative is intended to enhance operational efficiency and financial sustainability.

The subsidiaries affected and their respective wind-down methods